Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ, Jakobsen G, Arends J, Balstad TR, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM, Laird BJA; Cancer Cachexia Endpoints Working Group. Hjermstad MJ, et al. Among authors: greil c. J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):794-815. doi: 10.1002/jcsm.13453. Epub 2024 Mar 29. J Cachexia Sarcopenia Muscle. 2024. PMID: 38553255 Free PMC article. Review.
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS; Cancer Cachexia Endpoints Working Group. Vagnildhaug OM, et al. Among authors: greil c. J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):513-535. doi: 10.1002/jcsm.13434. Epub 2024 Feb 11. J Cachexia Sarcopenia Muscle. 2024. PMID: 38343065 Free PMC article. Review.
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE; Cancer Cachexia Endpoints Working Group. Brown LR, et al. Among authors: greil c. J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):816-852. doi: 10.1002/jcsm.13478. Epub 2024 May 13. J Cachexia Sarcopenia Muscle. 2024. PMID: 38738581 Free PMC article. Review.
Targeting Mitotic Exit in Malignant Cells.
Greil C, Engelhardt M, Felthaus J, Wäsch R. Greil C, et al. Methods Mol Biol. 2025;2874:199-205. doi: 10.1007/978-1-0716-4236-8_16. Methods Mol Biol. 2025. PMID: 39614057
Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ').
Valentini J, Froehlich D, Roesel I, Stolz R, Mahler C, Martus P, Klafke N, Horneber M, Witte C, Kramer K, Greil C, Gruen B, Tomaschko-Ubelaender K, Joos S; CCC-Integrativ Study Group. Valentini J, et al. Among authors: greil c. Front Med. 2024 Dec;18(6):1013-1025. doi: 10.1007/s11684-024-1097-z. Epub 2024 Nov 14. Front Med. 2024. PMID: 39542987
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, Lu S, Garassino M, Chargualaf M, Zhang Y, Howarth P, Uema D, Lisberg A, Sands J; TROPION-Lung01 Trial Investigators. Ahn MJ, et al. J Clin Oncol. 2024 Sep 9:JCO2401544. doi: 10.1200/JCO-24-01544. Online ahead of print. J Clin Oncol. 2024. PMID: 39250535
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials.
Popp I, Vaes RDW, Wieten L, Adebahr S, Hendriks L, Bavafaye Haghighi E, Degens J, Schäfer H, Greil C, Peeters S, Waller CF, Houben R, Niedermann G, Rawluk J, Gkika E, Duyster J, Grosu AL, De Ruysscher D. Popp I, et al. Among authors: greil c. Radiother Oncol. 2024 Jan;190:110048. doi: 10.1016/j.radonc.2023.110048. Epub 2023 Dec 7. Radiother Oncol. 2024. PMID: 38070686
42 results